We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.
- Authors
Murray, Macey L; Thompson, Mary; Santosh, Paramala J; Wong, Ian C K
- Abstract
Psychotropic medication prescribing for children and adolescents rose significantly between 2000 and 2002, including antidepressant prescribing. In 2003, the Committee on Safety of Medicines (CSM) advised against using venlafaxine or any selective serotonin receptor inhibitor (SSRI), with the exception of fluoxetine, for childhood and adolescent depression. The aim of this study was to compare the prevalence and incidence of children and adolescents who were prescribed antidepressants in UK primary care, before and after the CSM advice on antidepressant prescribing. We also compared paediatric antidepressant prescribing trends from Mediplus data with national antidepressant prescribing trends in England from the Prescription Pricing Authority (PPA).
- Publication
Drug safety, 2005, Vol 28, Issue 12, p1151
- ISSN
0114-5916
- Publication type
Journal Article
- DOI
10.2165/00002018-200528120-00009